Amina Farooq

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

Raj K. Maturi, Adam R. Glassman, Kristin Josic et al. · JAMA · 2023 · 60 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy

Maureen G. Maguire, Danni Liu, Susan B. Bressler et al. · JAMA Ophthalmology · 2021 · 33 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

Sensitivity of Staurosporine-Induced Differentiated RGC-5 Cells to Homocysteine

Preethi S. Ganapathy, Ying Dun, Yonju Ha et al. · Current Eye Research · 2009 · 30 citations

Life Sciences, Cell Biology, Neurobiology +17

Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial

Chelsea Fechter, Heather Frazier, William B. Marcus et al. · Ophthalmic surgery, lasers & imaging retina · 2016 · 26 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion

Ahmad A. Aref, Ingrid U. Scott, Paul VanVeldhuisen et al. · JAMA Ophthalmology · 2021 · 14 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15